These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Use of Reverse Vaccinology in the Design and Construction of Nanoglycoconjugate Vaccines against Burkholderia pseudomallei. Muruato LA; Tapia D; Hatcher CL; Kalita M; Brett PJ; Gregory AE; Samuel JE; Titball RW; Torres AG Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28903988 [No Abstract] [Full Text] [Related]
4. Correlates of immune protection following cutaneous immunization with an attenuated Burkholderia pseudomallei vaccine. Silva EB; Goodyear A; Sutherland MD; Podnecky NL; Gonzalez-Juarrero M; Schweizer HP; Dow SW Infect Immun; 2013 Dec; 81(12):4626-34. PubMed ID: 24101688 [TBL] [Abstract][Full Text] [Related]
5. LVS Δ Tullius MV; Bowen RA; Back PS; Masleša-Galić S; Nava S; Horwitz MA mBio; 2024 Apr; 15(4):e0018624. PubMed ID: 38511933 [TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide from Burkholderia thailandensis E264 provides protection in a murine model of melioidosis. Ngugi SA; Ventura VV; Qazi O; Harding SV; Kitto GB; Estes DM; Dell A; Titball RW; Atkins TP; Brown KA; Hitchen PG; Prior JL Vaccine; 2010 Nov; 28(47):7551-5. PubMed ID: 20837078 [TBL] [Abstract][Full Text] [Related]
7. Development of Subunit Vaccines That Provide High-Level Protection and Sterilizing Immunity against Acute Inhalational Melioidosis. Burtnick MN; Shaffer TL; Ross BN; Muruato LA; Sbrana E; DeShazer D; Torres AG; Brett PJ Infect Immun; 2018 Jan; 86(1):. PubMed ID: 29109172 [No Abstract] [Full Text] [Related]
8. A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection. Nieves W; Asakrah S; Qazi O; Brown KA; Kurtz J; Aucoin DP; McLachlan JB; Roy CJ; Morici LA Vaccine; 2011 Oct; 29(46):8381-9. PubMed ID: 21871517 [TBL] [Abstract][Full Text] [Related]
9. Development of Melioidosis Subunit Vaccines Using an Enzymatically Inactive Burkholderia pseudomallei AhpC. Schmidt LK; Orne CE; Shaffer TL; Wilson SM; Khakhum N; Torres AG; Brett PJ; Burtnick MN Infect Immun; 2022 Aug; 90(8):e0022222. PubMed ID: 35862715 [TBL] [Abstract][Full Text] [Related]
10. Identification of an OmpW homologue in Burkholderia pseudomallei, a protective vaccine antigen against melioidosis. Casey WT; Spink N; Cia F; Collins C; Romano M; Berisio R; Bancroft GJ; McClean S Vaccine; 2016 May; 34(23):2616-21. PubMed ID: 27091689 [TBL] [Abstract][Full Text] [Related]
11. Identification of a LolC homologue in Burkholderia pseudomallei, a novel protective antigen for melioidosis. Harland DN; Chu K; Haque A; Nelson M; Walker NJ; Sarkar-Tyson M; Atkins TP; Moore B; Brown KA; Bancroft G; Titball RW; Atkins HS Infect Immun; 2007 Aug; 75(8):4173-80. PubMed ID: 17517877 [TBL] [Abstract][Full Text] [Related]
14. Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders. Moustafa DA; Scarff JM; Garcia PP; Cassidy SK; DiGiandomenico A; Waag DM; Inzana TJ; Goldberg JB PLoS One; 2015; 10(7):e0132032. PubMed ID: 26148026 [TBL] [Abstract][Full Text] [Related]
15. Development of capsular polysaccharide-based glycoconjugates for immunization against melioidosis and glanders. Burtnick MN; Heiss C; Roberts RA; Schweizer HP; Azadi P; Brett PJ Front Cell Infect Microbiol; 2012; 2():108. PubMed ID: 22912938 [TBL] [Abstract][Full Text] [Related]
16. Humoral and cell-mediated adaptive immune responses are required for protection against Burkholderia pseudomallei challenge and bacterial clearance postinfection. Healey GD; Elvin SJ; Morton M; Williamson ED Infect Immun; 2005 Sep; 73(9):5945-51. PubMed ID: 16113315 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of a biodegradable microparticulate polymer as a carrier for Burkholderia pseudomallei subunit vaccines in a mouse model of melioidosis. Schully KL; Bell MG; Prouty AM; Gallovic MD; Gautam S; Peine KJ; Sharma S; Bachelder EM; Pesce JT; Elberson MA; Ainslie KM; Keane-Myers A Int J Pharm; 2015 Nov; 495(2):849-61. PubMed ID: 26428631 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of Burkholderia mallei ΔtonB Δhcp1 (CLH001) as a live attenuated vaccine in murine models of glanders and melioidosis. Khakhum N; Bharaj P; Myers JN; Tapia D; Walker DH; Endsley JJ; Torres AG PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007578. PubMed ID: 31306423 [TBL] [Abstract][Full Text] [Related]
19. BpOmpW Antigen Stimulates the Necessary Protective T-Cell Responses Against Melioidosis. Tomás-Cortázar J; Bossi L; Quinn C; Reynolds CJ; Butler DK; Corcoran N; Murchú MÓ; McMahon E; Singh M; Rongkard P; Anguita J; Blanco A; Dunachie SJ; Altmann D; Boyton RJ; Arnold J; Giltaire S; McClean S Front Immunol; 2021; 12():767359. PubMed ID: 34966388 [TBL] [Abstract][Full Text] [Related]
20. Rapid DNA vaccination against Burkholderia pseudomallei flagellin by tattoo or intranasal application. Lankelma JM; Wagemakers A; Birnie E; Haak BW; Trentelman JJA; Weehuizen TAF; Ersöz J; Roelofs JJTH; Hovius JW; Wiersinga WJ; Bins AD Virulence; 2017 Nov; 8(8):1683-1694. PubMed ID: 28323523 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]